MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
291.67%
Quick Ratio
267.43%
Debt to Asset Ratio
54.85%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Trade receivables, net
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued and other current liabil...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
34,121
34,762
42,907
47,120
Restricted cash
308
308
308
308
Marketable securities
204,431
189,238
178,075
143,948
Trade receivables, net
155,162
144,377
146,229
115,116
Inventory
38,879
37,391
22,634
22,419
Prepaid expenses and other current assets
34,770
31,980
21,079
20,313
Total current assets
467,671
438,056
411,232
349,224
Property, plant, and equipment, net
872
1,040
1,043
1,215
Intangible assets, net
13,687
14,250
14,812
15,375
Operating lease right-of-use asset
4,253
4,361
4,467
4,567
Other assets
2,054
2,296
1,419
596
Total assets
488,537
460,003
432,973
370,977
Accounts payable
6,604
18,296
12,528
5,795
Current portion of long-term debt, net
6,950
7,950
1,000
1,000
Accrued and other current liabilities
146,786
136,957
116,310
92,975
Total current liabilities
160,340
163,203
129,838
99,770
Operating lease liability, long-term
5,237
5,251
5,266
5,276
Long-term debt, net
101,950
101,470
107,959
107,498
Other long-term liabilities
431
431
431
360
Total liabilities
267,958
270,355
243,494
212,904
Common stock, 0.0001 par value 300,000 shares authorized at june30, 2026 and december31, 2025 125,591 and 123,333 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
12
12
12
12
Additional paid-in capital
1,355,593
1,339,529
1,327,595
1,313,602
Accumulated other comprehensive income (loss)
-656
-514
-44
-62
Accumulated deficit
-1,134,370
-1,149,379
-1,138,084
-1,155,479
Total stockholders equity
220,579
189,648
189,479
158,073
Total liabilities and stockholders equity
488,537
460,003
432,973
370,977
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$204,431K (73.12%↑ Y/Y)Trade receivables,net$155,162K (45.44%↑ Y/Y)Inventory$38,879K (138.17%↑ Y/Y)Prepaid expenses andother current assets$34,770K (86.58%↑ Y/Y)Cash and cashequivalents$34,121K (-53.09%↓ Y/Y)Restricted cash$308K (0.00%↑ Y/Y)Total current assets$467,671K (40.54%↑ Y/Y)Intangible assets, net$13,687K (-14.12%↓ Y/Y)Operating leaseright-of-use asset$4,253K (146.12%↑ Y/Y)Other assets$2,054K (244.63%↑ Y/Y)Property, plant, andequipment, net$872K (-37.45%↓ Y/Y)Total assets$488,537K (38.62%↑ Y/Y)Total liabilities andstockholders equity$488,537K (38.62%↑ Y/Y)Total liabilities$267,958K (25.53%↑ Y/Y)Total stockholdersequity$220,579K (58.72%↑ Y/Y)Accumulated deficit-$1,134,370K (2.45%↑ Y/Y)Accumulated othercomprehensive income (loss)-$656K (-1774.29%↓ Y/Y)Total currentliabilities$160,340K (54.27%↑ Y/Y)Long-term debt, net$101,950K (-4.76%↓ Y/Y)Operating leaseliability, long-term$5,237K (147.73%↑ Y/Y)Other long-termliabilities$431K (19.72%↑ Y/Y)Additional paid-in capital$1,355,593K (4.13%↑ Y/Y)Common stock, 0.0001par value 300,000...$12K (0.00%↑ Y/Y)Accrued and othercurrent liabilities$146,786K (67.08%↑ Y/Y)Current portion oflong-term debt, net$6,950K (795.00%↑ Y/Y)Accounts payable$6,604K (-56.21%↓ Y/Y)
logo-arcutis (1)-svg

Arcutis Biotherapeutics, Inc. (ARQT)

logo-arcutis (1)-svg

Arcutis Biotherapeutics, Inc. (ARQT)